Benzhexol acts to regulate the balance of dopamine and acetylcholine in the brain and improve Parkinson’s-related symptoms. Benzhexol is a central anticholinergic drug, which selectively blocks the cholinergic neural pathway in the striatum and has less effect on the periphery, thus facilitating the restoration of the balance of dopamine and acetylcholine in the brain of patients with Parkinson’s disease, and thus achieving the improvement of extrapyramidal symptoms caused by Parkinson’s such as muscle tonus, muscle tremor, and dullness of countenance. The common adverse reactions of this product include dry mouth, blurred vision, etc. Occasionally, tachycardia, nausea, vomiting, urinary retention, and constipation are seen. Drowsiness, depression, memory loss, hallucinations, and clouding of consciousness can occur with prolonged application. It is contraindicated in patients with glaucoma, urinary retention, and prostate hypertrophy. If there is a need for this product demand, it is recommended to apply under the guidance of a professional physician, do not blindly take on their own.